Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and Imiquimod

By Wagner T.L.   Ahonen C.L.   Couture A.M.   Gibson S.J.   Miller R.L.   Smith R.M.   Reiter M.J.   Vasilakos J.P.   Tomai M.A.  

Cellular Immunology, Vol. 191, Iss. 1, 1999-01 ,pp. : 10-19

Academic Press

Access to resources Recommend Favorite

Induction of Cytokines in Cynomolgus Monkeys by the Immune Response Modifiers, Imiquimod, S-27609 and S-28463

By Wagner T.L.   Horton V.L.   Carlson G.L.   Myhre P.E.   Gibson S.J.   Imbertson L.M.   Tomai M.A.  

Cytokine, Vol. 9, Iss. 11, 1997-11 ,pp. : 837-845

Academic Press

Access to resources Recommend Favorite

Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN

By Vasilakos J.P.   Smith R.M.A.   Gibson S.J.   Lindh J.M.   Pederson L.K.   Reiter M.J.   Smith M.H.   Tomai M.A.  

Cellular Immunology, Vol. 204, Iss. 1, 2000-08 ,pp. : 64-74

Academic Press

Access to resources Recommend Favorite

Dendritic Cell Maturation and Subsequent Enhanced T-Cell Stimulation Induced with the Novel Synthetic Immune Response Modifier R-848

By Ahonen C.L.   Gibson S.J.   Smith R.M.   Pederson L.K.   Lindh J.M.   Tomai M.A.   Vasilakos J.P.  

Cellular Immunology, Vol. 197, Iss. 1, 1999-10 ,pp. : 62-72

Academic Press

Access to resources Recommend Favorite

Induction of CD25 expression in human B lymphocytes by pharmacological activators of cellular signalling pathways

By McKay C.E.   Cushley W.  

Cytokine, Vol. 8, Iss. 4, 1996-04 ,pp. : 305-312

Academic Press

Access to resources Recommend Favorite